A significant treatment-related decrease in the incidence of mononuclear cell leukemia (MCL) was identified in Fischer-344/N rats for 20 chemicals tested in the National Toxicology Program's 2-yr carcinogenicity bioassay. Fourteen of the 20 chemicals caused decreases of MCL in both male and female rats; 6 of the 20 caused a significant decrease only in males and a marginal or no decrease in female rats. Seventeen of the chemicals associated with a decrease in MCL had a free aromatic amine or nitro functional groups that could be metabolized to free amines. With 1 exception, all 14 chemicals causing a decrease in MCL in both sexes produced spleen toxicity in the 13-wk studies. Reduced body weight and decreased survival, related either to toxicity or to an increase in other types of lethal neoplasms, did not contribute to the decreases in MCL observed in chemical exposure groups. Thirteen of the 20 chemicals were positive in Salmonella tests, and 15 were associated with increases in neoplasms at other sites in rats and/or mice, suggesting that different metabolites could be responsible for these varied biological effects.
INTRODUCTION
The National Toxicology Program (NTP) has studied the carcinogenic properties of more than 400 chemicals in long-term studies in rodents (27) . Evaluations of those studies have generally emphasized chronic, chemical-related toxicity and increases in the incidence of neoplasms in rodent model systems. For each NTP carcinogenicity study, significant treatment-related decreases in the more common neoplasms that occur spontaneously in control groups of rodents are also identified. Depending on the particular sex, strain, and rodent species, neoplasms with a high incidence rate in control groups occur in the liver, hematopoietic system, mammary gland, and other sites (15) . Mononuclear cell leukemia (MCL), also referred to as large granular lymphocyte ( LGL) leukemia, is a spontaneously occurring neoplasm of the hematopoietic system that has been well characterized in the Fischer-344/ N (F-344/N) rat strain (20, 34, 35, 37) . Based on biological and functional features in the F-344 rat, this neoplasm has been suggested as a model for LGL leukemia in humans (34) . In the F-344 rat, MCL is a rapidly progressive, lethal neoplastic disease that first develops in the spleen with infiltrates of neoplastic cells also occurring in the liver, lung, lymph nodes, bone marrow, and most other organs. It generally occurs in rats over 18 mo of age and over the course of a typical 2-yr study affects 46.7 and 26.8% of untreated male and female F-344/N rats, respectively (28) . This report identifies those chem-icals from NTP studies that caused a significant decrease in the incidence of MCL in male and female rats.
MATERIALS AND METHODS
Prechronic toxicity and 2-yr carcinogenicity studies described in this report were conducted in the male and female F-344/N rats obtained from National Institutes of Health animal colonies. The chemicals were administered to a core group of animals generally consisting of 50 animals/sex/species/dose level. The route of administration was inhalation (n = 1) or oral gavage (n = 3) 5 days/wk or daily administration in the diet (n = 16) for 13 wk or 2 yr; chemical structure, doses, and routes are provided in Tables I and II . The animals were housed at NTP contract facilities under GLP conditions as specified in the NTP Statement of Work; body weights, survival data, and pathology results were recorded for each study (27) . Details and results of genotoxicity tests for each have been previously reported (17, 22, 39~ 1 ) . From a review of all NTP studies using F-344 rats, we found that the overall frequency of chemical-related decreases in MCL far exceeded chance expectation (16) . From these studies with decreases, there was a subset of 20 chemicals showing a significant decrease in at least 1 but generally both sexes of rats. Some other studies with a statistically significant decrease in MCL were not included in this report because of unclear effects related to poor survival in dosed groups, lack of a dose response in the decrease of MCL, or only a marginal effect in 1 sex that resulted in incidence still within the historical control range. For each of the 20 chemicals identified, carcinogenic effects, mutagenicity, body weight, and survival data and prechronic toxicity findings were reviewed (Table I) .
For the analysis of the data on tumor incidence, survival-adjusted procedures were used to assess dose-response trends and to make pairwise comparisons between dosed groups and controls (14) . Fisher's exact test and the Cochran-Armitage trend test were also utilized to assess tumor incidence data (1, 12) . The level of significance was set at p < 0.05.
RESULTS
For 14 of the 20 chemicals causing a statistically significant decrease of MCL, the response was seen in both sexes of rats (Table IA, B). For the remaining 6 chemicals, the decrease was significant in males but only a marginal decrease was apparent in females.
After 13 wk of chemical exposure, there were treatment-related microscopic alterations in the spleen of male and female rats in 16 of the 20 studies. The spectrum of histopathologic alterations in the spleen included an increase in hematopoiesis and hemosiderin pigment accumulation in the red pulp and fibrosis of the capsule (Table  I) . Although a background presence of hematopoiesis and hemosiderin is normally seen in the spleen of young control rats, the increase in treated groups was readily identified when rats were examined without knowledge of treatment group. The no-effect dose levels and/or lowest administered dose levels for spleen toxicity in the 13-wk studies are shown in Table II . For each 2-yr study, the dose groups showing a decrease in MCL nearly always had spleen effects detected at the equivalent doses used in the 13-wk study. In 5 of the 14 prechronic studies where hematology was performed, anemia was present and the methemoglobin concentration was increased in the 3 instances where it was measured (data not shown). In the 2-yr studies, evidence of chronic toxicity in the spleen consisting of fibrosis, stromal metaplasia, or hemosiderin accumulation were generally limited to those chemicals such as the aniline compounds, which also produced a carcinogenic response (sarcomas) in the spleen (data not shown).
The treatment-related decreases in MCL were not associated with decreased body weight in groups of rats administered the test chemicals. At 1 yr into each study, the body weights for groups of dosed rats with a significant reduction in MCL were generally similar to those of controls (Table III) . In some instances, there were significant body weight reductions at the top dose, but reduced incidences of MCL were also seen at lower doses that caused no appreciable body weight effects. A possible exception was the l-amino-2-4-dibromoanthraquinone study, which had lower body weights (and reduced incidences of MCL) in all dosed groups.
The decrease in MCL for each of these studies was not attributed to reduced survival in treated groups at 2 yr.
For almost all studies, the percentage of survival in chemical exposure groups with a significant reduction in MCL was equal to or greater than that seen in contro15 (Table IV) .
NTP Salmonella test results were positive for 13 of the 20 chemicals and 15 of the 20 chemicals tested were carcinogenic at 1 or more target organ sites in rats and/ or mice (Table IA) . For several of these chemicals (i.e. p-nitrobenzoic acid), carcinogenicity was limited to a single site or sex/species combination whereas others (4,4,oxydianiline, l-amino-2-4-dibromoanthraquinone) were carcinogenic for most or all sex/species combinations and often affected multiple sites.
However, for 5 of the chemicals tested there was no evidence of carcinogenicity in either rodent species (Table IB). C.I. Pigment Red 23 was the only genotoxic (Salmonella-postive) chemical that decreased the incidence of MCL and caused no carcinogenic response at any site in rats or mice. Both C.I. Acid Orange 10 and hexylresorcinol were nongenotoxic and did not induce tumors at any site. Propyl gallate and phenylephrine hydrochloride were 2 other nongenotoxic, noncarcinogenic chemicals that caused a significant decrease in MCL in males but had only a marginal effect in females.
DISCUSSION
For each of the 20 chemical studies identified in this article, the treatment-related decrease in MCL was clear.
The high spontaneous incidences typically seen in control males (46.7%) and females (26.8%) were often reduced to 2% or less in dosed groups. The study of H.C. Blue 1 was the only instance where there was no decrease in female rats, but the overall low incidence of MCL in that study for both treated and control groups of females (6-10%) may have reduced the sensitivity of the test to detect a potential effect in that sex. There was some variability in the incidence of MCL between control groups in these studies that can be attributed to differences in vehicle (corn oil vs untreated), increases attributed to genetic drift over time, or changes in diagnostic criteria for MCL (15) .
For these studies, it appears that chemical structure, spleen toxicity, and other biological effects of these chemicals were important in causing the observed decreases of MCL. Seventeen of these chemicals contain free aromatic amine functional groups, azo linkages, other aromatic structural components, or, in the case of 2 aliphatic chemicals (isobutyl nitrite and 11-aminoundecanoic acid), a free amine or grouping capable of being metabolized to an amine. Exposure to nitroaromatic compounds in a variety of animal species and humans can cause hematological toxicity (1, 19, 33) . The metabolite thought to be responsible is a hydroxyamino-compound (10) . N-hydroxy chemical derivatives have been proposed to cause the formation of methemoglobin, Heinz body anemia, and removal of damaged erythrocytes by . the spleen (3, 4, 6, 13) . 1 Chemical-related spleen toxicity or cytotoxicity/mutagenicity specific for the MCL precursor cell may be an L important mechanism for the decreased incidence of . MCL seen in many of the studies. It has been shown that i the spleen has a critical role in the pathogenesis of MCL. a Percentage of animals with leukemia. Percentages given in increasing order of dose level beginning with control. In the current NTP historical control database for doses feed studies, the mean percent for MCL is 46.5% (range 14-52%) in female rats (26) . b + = evidence of carcinogenicity; -= no evidence or uncertain findings. C Site of carcinogenic response in rats and mice. A = adrenal medulla; Cl = clitoral gland; F = forestomach; Ha = Harderian gland; He = hemangiosarcoma; I = intestine; K = kidney; L = liver; Lu = lung; Ma = mammary gland; Ov = ovary; P = preputial gland; Sp = spleen; Ty = thyroid; Ub = urinary bladder. d + = positive; -= negative; :t = uncertain findings. e NCI Technical Report No. a Ppm for feed and inhalation studies; mg/kg/day for gavage studies. Dose levels in 2-yr study with significant decreases in MCL are bold; -indicates no middose group. For 13-wk study, LOEL = lowest-observed-effect level for hemosiderin pigment, hematopoiesis, and/or fibrosis; NOEL = no-observed-effect level, i.e. highest dose at which splenic toxicity was not observed. L = low dose; M = middose; H = high dose; ND = not determined because the lowest administered dose had an effect or in a few cases only the spleen from the highest dose was examined; NSE = no spleen effect seen with this chemical. zone of the white pulp and later extend throughout the red pulp (20, 34, 37) . Splenectomy of young rats effectively prevents the development of MCL later in life (21) . For 16 of the 20 chemicals in this group, spleen toxicity was characterized morphologically by increased hemosiderin pigment accumulation, hematopoiesis, and/or fibrosis. Chemical-related damage to erythrocytes and their sequestration in the spleen was also indicated by hematological data in 5 studies showing anemia and increased methemoglobin levels. It has been proposed that increased hemosiderin accumulation, sequestration of chemical on damaged erthryocytes, and/or chronic splenic congestion with hemorrhage and scarring are related to the eventual development of sarcomas in the spleen (6, 13, 38) . It is possible that similar mechanisms may have sufficiently altered the microenvironment in the spleen to suppress the eventual development of MCL. Increased hematopoiesis and/or hemosiderin accumulation related to treatment have occurred in the spleen of rats from approximately 10 to 15% of NTP 13-wk toxicity studies and therefore are not always predictive of a treatment-related decrease in MCL at the end of a 2-yr study. Hematopoiesis/hemosiderin pigment accumulation in the spleen also occurred in several studies excluded from this report because the decreases in MCL were only marginal, not dose-related, or were simply attributable to poor survival in treated groups. There were also a few instances where spleen toxicity was present at 13 wk, but the incidence of MCL was not affected in the 2-yr studies. For example, in the 13-wk studies of malonaldehyde (23) and 2,4-diaminophenol dihydrochloride (24) , hematopoiesis was increased in the spleen of male rats, but there was no effect on the incidence of MCL. However, in both of these examples, the highest dose of chemical administered to male rats in the 2-yr studies was only at 20-25% of the dose where a spleen effect was seen in the 13-wk studies. It is possible that exposure to higher concentrations of chemical in the 2-yr studies would have caused a reduction in MCL. We found that all chemicals that caused toxicity in the spleen in prechronic studies decreased the incidence of MCL if equivalent doses were used in the 2-yr study. In addition, there was no evidence in NTP studies that toxicity in the spleen has been associated with increases in MCL. In 4 NTP studies (furan, C.I. Direct Blue 15, iodinated glycerol, and dimethyl morpholinophosphoramidate) where a carcinogenic response in rats was based on a treatment-related increase for MCL in one or both sexes, evidence of spleen toxicity was not present at 13 wk.
Some of the chemicals that cause spleen toxicity at 13 wk may affect the development of MCL through mechanisms in addition to this alteration of the spleen microenvironment. When 3 glycol ethers were tested in a leukemia transplantation model, progression of the transplanted MCL was markedly inhibited following administration of methoxyethanol (ME) or ethoxyethanol (EE), but this effect was not seen with butoxyethanol (BE) (9). In the 13-wk studies for each of these chemicals, spleen toxicity, including increased hematopoiesis, hemosiderin accumulation, and/or fibrosis occurred (25) . Because it has been shown that splenectomy of rats prior to injection of a suspension of MCL cells does not alter the course of the disease (37) , suppression of MCL transplanted cells by EE and ME and a lack of effect of BE in the transplant model suggest that factors in addition to spleen toxicity may be important.
In 4 of the 20 studies showing a reduction in MCL, there was no evidence of erythrocyte/spleen toxicity, and for 2 other chemicals (isobutyl nitrite and hexylresorcinol) the doses administered in the 2-yr study were well below the lowest-observed-effect level for spleen toxicity in the 13-wk studies. This further suggests that the inhibited development or progression of the MCL may not always be secondary to alteration of spleen structure and function. For example, factors related to the bacteriostatic activity of chemicals such as 4-hexylresorcinol (7) and nitrobenzoic acid (32) could possibly also affect cell proliferation/growth and development of MCL in the F-344/ N rat (26) . In addition to the decrease in MCL seen in the 2-yr study of hexylresorcinol, suppressed progression of MCL by this chemical has been reported in a transplantation model (8) .
It is important to note that in this group of 20 chemicals reduction in MCL was not predictive for absence of a carcinogenic effect, as 15 showed a treatment-related increase in neoplasms at 1 or more sites in rats and/or mice. Seventeen (85%) of these chemicals contained an amino/nitro-type structure. In a review of 301 NTP carcinogenicity studies for structure/activity relationships, 84 (28%) of those chemicals had aromatic amino/nitro-TABLE IV-Survival (%) in dosed and control F-344 rats in 20 2-yr studies with chemical-related decreases in MCL. a L = low dose; M = middose; H = high dose; -indicates no middose group. type groups, 59/84 (70%) were rodent carcinogens, and 72 (86%) were mutagenic to Salmonella (2) . While the mutagenicity, as determined by Salmonalla assay, for the majority of the 20 chemicals in this report may have contributed to the increase in tumors at other sites, these chemicals or their metabolites may exert different biologic effects and, like anti-cancer agents (5) , can in some cases cause a decrease in the incidence of MCL.
In addition to possible chemical-specific effects, other factors suggested or shown to contribute to a reduction of MCL in the rat include poor survival, decreased body weight, and alteration of dietary fat. There was no evidence in these 20 studies that generalized toxicity or the occurrence of other types of fatal neoplasms reduced the chance for MCL to develop in the treated groups. In fact, for some studies an improved survival in chemical exposure groups may have been due to the chemical-related decrease in MCL. In the study of p-chloroaniline, survival of male rats was significantly increased in the lowdose (64%) and middose (64%) groups compared to controls (36%); MCL occurred in only 6 and 4% of the lowand middose groups, respectively, but in 42% of the controls. Survival of the high-dose group (42%) was similar to the controls, as increased mortality in that group was related to treatment-related sarcomas in the spleen. Because spleen sarcomas did not cause early deaths in female rats, the increased survival and reduction in MCL were similar in all dosed groups relative to controls.
In the 20 studies we evaluated, body weight decreases often did not occur or were generally less than 10% in the dosed groups showing significant decreases in MCL. Decreases in the incidence of several commonly occurring neoplasms, particularly of endocrine origin, have been correlated with significantly lower body weight in rodents (31) . The effect of decreased body weight on the incidence of MCL has not been consistently demonstrated. In one report, a 33% restriction of ad libitum feed intake resulted in a reduced body weight and significant decrease in the incidence of MCL in F-344/N male but not female rats (18) . A subsequent study using a 40% dietary restriction showed no effect on the incidence of MCL in either sex (36) .
Dietary alteration in control groups by daily gavage administration of com oil has been shown to consistently reduce the incidence of MCL in male rats. In approximately 60 chronic studies, corn oil gavage reduced the incidence of MCL in male rats from 38 to 19% (30) . In
